{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:45:36Z","timestamp":1783464336346,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21176-2","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:55:05Z","timestamp":1761296105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Increased cancer risk in patients with IgG4-related disease in a nationwide South Korean cohort, 2012\u20132021"],"prefix":"10.1038","volume":"15","author":[{"given":"Hoonsub","family":"So","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sojeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8012-7364","authenticated-orcid":false,"given":"Doo-Ho","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"21176_CR1","doi-asserted-by":"publisher","unstructured":"Yu, K. H., Kuo, C. F., Huang, L. H., Huang, W. K. & See, L. C. Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: A nationwide Population-Based dynamic cohort study in Taiwan. Med. (Baltim). 95e3540. https:\/\/doi.org\/10.1097\/md.0000000000003540 (2016).","DOI":"10.1097\/md.0000000000003540"},{"key":"21176_CR2","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/s2665-9913(19)30017-7","volume":"1","author":"W Zhang","year":"2019","unstructured":"Zhang, W. & Stone, J. H. Management of IgG4-related disease. Lancet Rheumatol. 1, e55\u2013e65. https:\/\/doi.org\/10.1016\/s2665-9913(19)30017-7 (2019).","journal-title":"Lancet Rheumatol."},{"key":"21176_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4078\/jrd.2023.0023","volume":"31","author":"J Yeo","year":"2024","unstructured":"Yeo, J. et al. Immunoglobulin G4-related hypertrophic pachymeningitis with an isolated scalp mass mimicking a brain tumor: a case report and literature review. J. Rheum. Dis. 31, 54\u201358. https:\/\/doi.org\/10.4078\/jrd.2023.0023 (2024).","journal-title":"J. Rheum. Dis."},{"key":"21176_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s10165-011-0520-x","volume":"22","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto, M. et al. Risk of malignancies in IgG4-related disease. Mod. Rheumatol. 22, 414\u2013418. https:\/\/doi.org\/10.1007\/s10165-011-0520-x (2012).","journal-title":"Mod. Rheumatol."},{"key":"21176_CR5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/ajg.2012.465","volume":"108","author":"M Shiokawa","year":"2013","unstructured":"Shiokawa, M. et al. Risk of cancer in patients with autoimmune pancreatitis. Am. J. Gastroenterol. 108, 610\u2013617. https:\/\/doi.org\/10.1038\/ajg.2012.465 (2013).","journal-title":"Am. J. Gastroenterol."},{"key":"21176_CR6","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3899\/jrheum.150436","volume":"42","author":"J Asano","year":"2015","unstructured":"Asano, J. et al. Association between Immunoglobulin G4-related disease and malignancy within 12 years after diagnosis: an analysis after longterm followup. J. Rheumatol. 42, 2135\u20132142. https:\/\/doi.org\/10.3899\/jrheum.150436 (2015).","journal-title":"J. Rheumatol."},{"key":"21176_CR7","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1038\/s41598-020-61585-z","volume":"10","author":"H Tang","year":"2020","unstructured":"Tang, H. et al. Malignancy and IgG4-related disease: the incidence, related factors and prognosis from a prospective cohort study in China. Sci. Rep. 10, 4910. https:\/\/doi.org\/10.1038\/s41598-020-61585-z (2020).","journal-title":"Sci. Rep."},{"key":"21176_CR8","unstructured":"Service, K. S. I. Cancer Registration Statistics. Statistics Korea http:\/\/kosis.kr\/ (2024)."},{"key":"21176_CR9","doi-asserted-by":"publisher","unstructured":"Umehara, H. et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), Mod Rheumatol 22, 21\u201330. (2011). https:\/\/doi.org\/10.1007\/s10165-011-0571-z (2012).","DOI":"10.1007\/s10165-011-0571-z"},{"key":"21176_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40, 373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8 (1987).","journal-title":"J. Chronic Dis."},{"key":"21176_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/MPA.0b013e31819d73ca","volume":"38","author":"N Takahashi","year":"2009","unstructured":"Takahashi, N., Ghazale, A. H., Smyrk, T. C., Mandrekar, J. N. & Chari, S. T. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas 38, 523\u2013526. https:\/\/doi.org\/10.1097\/MPA.0b013e31819d73ca (2009).","journal-title":"Pancreas"},{"key":"21176_CR12","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/1756-185x.13093","volume":"20","author":"SS Ahn","year":"2017","unstructured":"Ahn, S. S., Song, J. J., Park, Y. B. & Lee, S. W. Malignancies in Korean patients with Immunoglobulin G4-related disease. Int. J. Rheum. Dis. 20, 1028\u20131035. https:\/\/doi.org\/10.1111\/1756-185x.13093 (2017).","journal-title":"Int. J. Rheum. Dis."},{"key":"21176_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13075-021-02652-2","volume":"24","author":"T Yu","year":"2022","unstructured":"Yu, T. et al. The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis. Arthritis Res. Ther. 24, 14. https:\/\/doi.org\/10.1186\/s13075-021-02652-2 (2022).","journal-title":"Arthritis Res. Ther."},{"key":"21176_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdsr.2022.12.002","volume":"59","author":"T Maehara","year":"2023","unstructured":"Maehara, T., Koga, R. & Nakamura, S. Immune dysregulation in Immunoglobulin G4-related disease. Jpn Dent. Sci. Rev. 59, 1\u20137. https:\/\/doi.org\/10.1016\/j.jdsr.2022.12.002 (2023).","journal-title":"Jpn Dent. Sci. Rev."},{"key":"21176_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1054\/bjoc.2001.1943","volume":"85","author":"KJ O\u2019Byrne","year":"2001","unstructured":"O\u2019Byrne, K. J. & Dalgleish, A. G. Chronic immune activation and inflammation as the cause of malignancy. Br. J. Cancer. 85, 473\u2013483. https:\/\/doi.org\/10.1054\/bjoc.2001.1943 (2001).","journal-title":"Br. J. Cancer"},{"key":"21176_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4078\/jrd.2024.0129","volume":"32","author":"HH Son","year":"2025","unstructured":"Son, H. H. & Moon, S. J. Pathogenesis of systemic sclerosis: an integrative review of recent advances. J. Rheum. Dis. 32, 89\u2013104. https:\/\/doi.org\/10.4078\/jrd.2024.0129 (2025).","journal-title":"J. Rheum. Dis."},{"key":"21176_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archinternmed.2007.107","volume":"168","author":"S Bernatsky","year":"2008","unstructured":"Bernatsky, S., Clarke, A. E. & Suissa, S. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch. Intern. Med. 168, 378\u2013381. https:\/\/doi.org\/10.1001\/archinternmed.2007.107 (2008).","journal-title":"Arch. Intern. Med."},{"key":"21176_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3332\/ecancer.2017.781","volume":"11","author":"C Verbaanderd","year":"2017","unstructured":"Verbaanderd, C. et al. Repurposing drugs in oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents. Ecancermedicalscience 11, 781. https:\/\/doi.org\/10.3332\/ecancer.2017.781 (2017).","journal-title":"Ecancermedicalscience"},{"key":"21176_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/jgh.16066","volume":"38","author":"K Kubota","year":"2023","unstructured":"Kubota, K. et al. Reducing relapse through maintenance steroid treatment can decrease the cancer risk in patients with IgG4-sclerosing cholangitis: based on a Japanese nationwide study. J. Gastroenterol. Hepatol. 38, 556\u2013564. https:\/\/doi.org\/10.1111\/jgh.16066 (2023).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"21176_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.amepre.2013.10.029","volume":"46","author":"MC White","year":"2014","unstructured":"White, M. C. et al. Age and cancer risk: a potentially modifiable relationship. Am. J. Prev. Med. 46, 7\u201315. https:\/\/doi.org\/10.1016\/j.amepre.2013.10.029 (2014).","journal-title":"Am. J. Prev. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21176-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21176-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21176-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T21:02:33Z","timestamp":1761339753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21176-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21176"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21176-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki. The Institutional Review Board of Ulsan University Hospital approved the study (Ulsan, Korea) (IRB number: 2023-03-030) and waived the requirement for informed consent because this study utilized a public database and did not collect personally identifiable information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"37273"}}